Literature DB >> 11562623

Tyrosine supplementation in phenylketonuria: diurnal blood tyrosine levels and presumptive brain influx of tyrosine and other large neutral amino acids.

L R Kalsner1, F J Rohr, K A Strauss, M S Korson, H L Levy.   

Abstract

UNLABELLED: Tyrosine supplementation has not consistently been found to improve neuropsychologic function in phenylketonuria (PKU), possibly because of failure to achieve adequate levels of tyrosine in the brain.
OBJECTIVES: To evaluate blood levels achieved after tyrosine supplementation in treated PKU and calculate brain influxes of tyrosine and other large neutral amino acids before and with tyrosine supplementation. STUDY
DESIGN: Ten subjects with PKU receiving a phenylalanine-restricted diet were studied over 48 hours; each received tyrosine supplementation (300 mg/kg) on day 2. Plasma phenylalanine and tyrosine were measured every 2 hours, and all free amino acids were measured every 6 hours. Brain influxes of tyrosine and other large neutral amino acids were calculated.
RESULTS: Plasma tyrosine levels were low normal at baseline. With supplementation there was a substantial but unsustained rise in plasma tyrosine. Calculated brain influx of tyrosine was 27% +/- 19% of normal before supplementation, increasing to 90% +/- 58% of normal with supplementation. Nevertheless, calculated influx remained less than 70% of normal at 50% of the time points. The calculated brain influxes of all other large neutral amino acids except tryptophan were 20% to 40% of normal before and with tyrosine supplementation.
CONCLUSIONS: Tyrosine supplementation in the diet for PKU produces marked but nonsustained increases in plasma tyrosine levels, with calculated brain influx that often remains suboptimal. This could explain the lack of consistent neuropsychologic benefit with tyrosine supplementation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11562623     DOI: 10.1067/mpd.2001.117576

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Phenylalanine induces oxidative stress and decreases the viability of rat astrocytes: possible relevance for the pathophysiology of neurodegeneration in phenylketonuria.

Authors:  Thales Preissler; Ivi Juliana Bristot; Bruna May Lopes Costa; Elissa Kerli Fernandes; Elenara Rieger; Vanessa Trindade Bortoluzzi; Itiane Diehl de Franceschi; Carlos Severo Dutra-Filho; José Claudio Fonseca Moreira; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2015-11-16       Impact factor: 3.584

Review 2.  Recommendations for the nutrition management of phenylalanine hydroxylase deficiency.

Authors:  Rani H Singh; Fran Rohr; Dianne Frazier; Amy Cunningham; Shideh Mofidi; Beth Ogata; Patricia L Splett; Kathryn Moseley; Kathleen Huntington; Phyllis B Acosta; Jerry Vockley; Sandra C Van Calcar
Journal:  Genet Med       Date:  2014-01-02       Impact factor: 8.822

3.  Solvothermal Preparation of a Lanthanide Metal-Organic Framework for Highly Sensitive Discrimination of Nitrofurantoin and l-Tyrosine.

Authors:  Tian-Tian Wang; Jing-Yi Liu; Rui Guo; Jun-Dan An; Jian-Zhong Huo; Yuan-Yuan Liu; Wei Shi; Bin Ding
Journal:  Molecules       Date:  2021-06-16       Impact factor: 4.411

4.  Optimising amino acid absorption: essential to improve nitrogen balance and metabolic control in phenylketonuria.

Authors:  Anita MacDonald; Rani H Singh; Júlio César Rocha; Francjan J van Spronsen
Journal:  Nutr Res Rev       Date:  2018-10-04       Impact factor: 7.800

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.